A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Alcon

Status and phase: Completed; Phase 3

Conditions: Open-angle Glaucoma; Ocular Hypertension

Treatments: Drug: Travoprost (TRAVATAN); Drug: Travoprost, Investigational

Study type: Interventional

Funder types: Industry

Identifiers

NCT00293761

C-05-51

Details and patient eligibility

About

The purpose of the study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension

Enrollment: 109 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients of either sex of any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension.
• Other protocol-defined inclusion criteria may apply.

Exclusion criteria

• Under age 18.
• Other protocol-defined exclusion criteria may apply.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

109 participants in 2 patient groups

Travatan, Investigational

Experimental group

Treatment:

Drug: Travoprost, Investigational

Travatan

Active Comparator group

Treatment:

Drug: Travoprost (TRAVATAN)